Rxo (RXO) Other financing activities (2021 - 2025)

Rxo (RXO) has reported Other financing activities for 5 consecutive years, with -$10.0 million the latest figure, recorded in Q2 2025.

• Other financing activities for Q2 2025 came in at -$10.0 million, down 900.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.0 million (down 133.33% YoY), and the FY2025 annual result was -$10.0 million, down 133.33% from the prior year.
• Other financing activities was -$10.0 million for Q2 2025 at Rxo, down from $21.0 million in the prior quarter.
• Over five years, Other financing activities peaked at $21.0 million in Q4 2024 and troughed at -$10.0 million in Q2 2025.
• Average Other financing activities over 5 years is $3.1 million, with a median of $1.0 million recorded in 2022.
• Year-over-year, Other financing activities jumped 900.0% in 2022 and sank 900.0% in 2025.
• Over 5 years, Other financing activities stood at -$1.0 million in 2021, then surged by 900.0% to $8.0 million in 2022, then slumped by 87.5% to $1.0 million in 2023, then surged by 2000.0% to $21.0 million in 2024, then sank by 147.62% to -$10.0 million in 2025.
• Per Business Quant data, the three most recent Other financing activities figures were -$10.0 million in Q2 2025, $21.0 million in Q4 2024, and $10.0 million in Q3 2024.